Kolexia
Chauvenet Marion Gastro-entérologie
Chauvenet Marion
Gastro-entérologie
Hôpital Lyon Sud
Pierre-Bénite, France
81 Activités
344 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Tumeurs du côlon Adénocarcinome Tumeurs du foie Tumeurs du poumon Tumeurs du pancréas Maladie de Crohn Adénomes Métastase tumorale

Collaborateurs

Voir plus
Nancey Stephane
Nancey Stephane
Hôpital Lyon Sud, Pierre-Bénite, France
Boschetti Gilles
Boschetti Gilles
Hôpital Lyon Sud, Pierre-Bénite, France
Flourie Bernard
Flourie Bernard
Hôpital Lyon Sud, Pierre-Bénite, France
Guillet Marielle
Guillet Marielle
Hôpital La Croix-Rousse, Lyon, France

Industries

Voir plus
Amgen
8 collaboration(s)
Dernière en 2023
Pierre Fabre
4 collaboration(s)
Dernière en 2023
Sanofi
3 collaboration(s)
Dernière en 2021
Abbvie
3 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
MOST plus: A Two-period, Multicenter, Randomized, Open-label, Phase II Study Evaluating the Clinical Benefit of a Maintenance Treatment Targeting Tumor Molecular Alterations in Patients With Progressive Locally-advanced or Metastatic Solid Tumors
Essai Clinique (Centre Léon-Bérard)   09 février 2024
1684TiP PARPiPANC: A multicentric, single arm, phase II assessing niraparib as first line therapy for patients with metastatic homologous repair-deficient pancreatic cancer
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
POCHI: Pembrolizumab in Combination With Xelox Bevacizumab in Patients With Microsatellite Stable Mestatic Colorectal Cancer and a High Immune Infiltrate : a Proof of Concept Study
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   16 août 2023
TEDOPAM: A Randomized Non-comparative Phase II Study of Maintenance Therapy With OSE2101 Plus FOLFIRI, or FOLFIRI After Induction Therapy With FOLFIRINOX in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (TEDOPaM-D17-01 PRODIGE 63 Study)
Essai Clinique (Ose Immunotherapeutics)   24 février 2023
Preoperative chemoradiation (CRT) with carboplatin (CBP)/paclitaxel (PCL) (CP) or with 5-fluorouracil (FU)/oxaliplatin (OX) (Fx) for esophageal or junctional cancer: A randomized phase 2 trial.
2022 ASCO Annual Meeting I   02 juin 2022
Chemotherapy (doublet or triplet) plus targeted therapy by RAS status as conversion therapy in colorectal cancer patients with initially unresectable liver-only metastases. The UNICANCER PRODIGE-14 randomised clinical trial.
British journal of cancer   06 janvier 2022
Impact of the First Wave of the COVID-19 Pandemic on the Lyon University Hospital Cancer Institute (IC-HCL).
Cancers   22 décembre 2021
IMMUCARE-BASE: A Clinical and Biological Prospective Database of Patients Treated With Anticancer Immunotherapy and Follow up of Their Immune-related Adverse Events irAE
Essai Clinique (Hospices Civils de Lyon)   26 juillet 2021
ONCOPRO: Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients
Essai Clinique (Hospices Civils de Lyon)   12 juillet 2021
Intestinal Conventional Ultrasonography, Contrast-Enhanced Ultrasonography and Magnetic Resonance Enterography in Assessment of Crohn's Disease Activity: A Comparison with Surgical Histopathology Analysis.
Digestive diseases and sciences   30 mai 2021